Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dose response studies. I. Some design considerations

S J Ruberg1

  • 1Marion Merrell Dow Inc., Kansas City, Missouri 64134-0627, USA.

Journal of Biopharmaceutical Statistics
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paradigm shifts in clinical trials enabled by information technology.

Statistics in medicine·2001
Same author

Detecting dose response with contrasts.

Statistics in medicine·2000
Same author

Randomization tests for assessing the equality of area under curves for studies using destructive sampling.

Journal of applied toxicology : JAT·1996
Same author

Factorial dose-response studies using frequency and magnitude of dose.

Journal of biopharmaceutical statistics·1996
Same author

Dose response studies. II. Analysis and interpretation.

Journal of biopharmaceutical statistics·1995
Same author

Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1.

Biopharmaceutics & drug disposition·1992
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Understanding compound dose response is vital in biomedical research. This article discusses clinical trial designs for dose-response studies, focusing on efficacy and safety, and minimum effective dose identification.

Area of Science:

  • Biomedical Research
  • Clinical Pharmacology
  • Drug Development

Background:

  • Characterizing the dose-response relationship is crucial for evaluating compound efficacy, safety, and benefit/risk ratio in biomedical research.
  • This principle applies to both preclinical laboratory experiments and clinical trials.
  • Effective clinical trial design is essential for accurate dose-response assessment.

Purpose of the Study:

  • To address key clinical trial design issues pertinent to dose-response studies.
  • To provide insights into trials for identifying the minimum effective dose.
  • To discuss the application of randomized concentration-controlled trials and one-sided hypotheses in study design.

Main Methods:

  • Focuses on the design aspects of clinical trials for dose-response characterization.

Related Experiment Videos

  • Reviews considerations for identifying minimum effective dose.
  • Examines the use of randomized concentration-controlled trials and one-sided hypotheses.

    • Main Results:

    • Highlights critical design considerations for dose-response studies in clinical trials.
    • Discusses strategies for optimizing trial designs to accurately assess compound effects.
    • Part I focuses on design, with Part II covering analysis strategies.

    Conclusions:

    • Proper clinical trial design is fundamental for characterizing compound dose-response relationships.
    • The design choices discussed impact the ability to determine efficacy, safety, and optimal dosing.
    • This paper serves as a foundational guide to dose-response study design in clinical research.